Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Harmony Biosciences Holdings, Inc. (HRMY) had Debt to Equity Ratio of 0.19 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$868.45M |
|
$158.69M |
|
$198.34M |
|
$670.11M |
|
$659.98M |
|
$208.47M |
|
$6.59M |
|
$215.06M |
|
$215.06M |
|
$158.69M |
|
$158.69M |
|
$158.69M |
|
$158.69M |
|
$208.47M |
|
$232.93M |
|
57.49M |
|
58.54M |
|
$2.76 |
|
$2.71 |
|
| Balance Sheet Financials | |
$907.01M |
|
-- |
|
$364.62M |
|
$1.27B |
|
$252.13M |
|
$143.66M |
|
$149.28M |
|
$401.41M |
|
$870.22M |
|
$780.80M |
|
$870.22M |
|
57.73M |
|
| Cash Flow Statement Financials | |
$348.20M |
|
$-39.65M |
|
$-9.05M |
|
$453.27M |
|
$752.77M |
|
$299.50M |
|
$44.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.60 |
|
-- |
|
-- |
|
0.14 |
|
|
Debt to Equity Ratio |
0.19 |
77.16% |
|
24.00% |
|
24.00% |
|
26.82% |
|
24.76% |
|
18.27% |
|
$347.89M |
|
-- |
|
-- |
|
-- |
|
0.68 |
|
37.02 |
|
8.97 |
|
40.68 |
|
18.24% |
|
20.32% |
|
12.48% |
|
15.65% |
|
$15.07 |
|
$5.94 |
|
$5.95 |
|